COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?

Juan León-Román(Vall d'Hebron Hospital Universitari), Irene Agraz(Vall d'Hebron Hospital Universitari), Ander Vergara(Vall d'Hebron Hospital Universitari), Natàlia Ramos(Vall d'Hebron Hospital Universitari), Néstor Toapanta(Vall d'Hebron Hospital Universitari), Clara García-Carro(Hospital Clínico San Carlos), Alejandra Gabaldón(Vall d'Hebron Hospital Universitari), Roxana Bury(Vall d'Hebron Hospital Universitari), Sheila Bermejo(Vall d'Hebron Hospital Universitari), Oriol Bestard(Vall d'Hebron Institut de Recerca), María José Soler(Instituto de Salud Carlos III)
Clinical Kidney Journal
March 11, 2022
Cited by 12Open Access
Full Text

Abstract

ABSTRACT Novel coronavirus disease infection (coronavirus disease 2019, COVID-19) was declared a global pandemic in March 2020 and since then has become a major public health problem. The prevalence of COVID-19 infection and acute kidney injury (AKI) is variable depending on several factors such as race/ethnicity and severity of illness. The pathophysiology of renal involvement in COVID-19 infection is not entirely clear, but it could be in part explained by the viral tropism in the kidney parenchyma. AKI in COVID-19 infection can be either by direct invasion of the virus or as a consequence of immunologic response. Diverse studies have focused on the effect of COVID-19 on glomerulonephritis (GN) patients or the ‘novo’ GN; however, the effect of COVID-19 in acute tubulointerstitial nephritis (ATIN) has been scarcely studied. In this article, we present five cases with different spectrums of COVID-19 infection and ATIN that may suggest that recent diagnosis of ATIN is accompanied by a worse clinical prognosis in comparison with long-term diagnosed ATIN.


Related Papers

No related papers found

Powered by citation graph analysis